Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Opioid Treatments Could Get Survival Claim As US FDA Develops Protocol

Dec 02 2017

• By Brenda Sandburg

Related Content

Generic Abuse-Deterrent Opioids: Comparison To Brand Will Not Require Use Of Control

Nov 21 2017

US FDA May Change Opioid Labeling To Limit Dispensing By Indication

Sep 15 2017

Addiction Recovery Medications' 'Stigma' Needs To Be Eliminated, Gottlieb Says

Oct 26 2017

Opioid Packaging Changes Might Deter Abuse – And Generic Competition

Oct 31 2017

Related Companies

Indivior plc

Additional Topics

United States Regulation FDA Drug Approval Standards BioPharmaceutical

More from US FDA

More from Agency Leadership

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.